Hunter Capital AB Stock

Stocks

End-of-day quote NORDIC GROWTH MARKET Other stock markets 2026-08-06			5-day change	1st Jan Change
10.15 ^SEK	-7.73%		-0.98%	-27.50%

07-31	Hunter Capital raises its offer for C100 after correction	FW
07-29	Hunter Capital submits mandatory offer for C100 (update)	FW

07-31	Hunter Capital raises its offer for C100 after correction	FW
07-29	Hunter Capital submits mandatory offer for C100 (update)	FW
07-29	Hunter Capital makes a mandatory offer for C100	FW
07-15	Hunter Capital cuts stake in C100 ahead of mandatory takeover offer	FW
07-07	Hunter Capital sells shares in C100 for just over 3 million kronor	FW
07-02	Hunter Capital to cross mandatory bid threshold in C100	FW
06-10	Hunter Capital provides supplementary information on subsidiary divestment	FW
05-25	C100 acquires Hunter Capital subsidiary in related-party transaction	FW
05-24	C100 AB agreed to acquire Hunter Capital Dry Eye IPR AB from Hunter Capital AB.	CI
05-21	Hunter Capital transfers patents to new subsidiary	FW
05-07	Hunter Capital reports minor changes as expected - Acting CEO: RTO 1 deal demonstrates how value can be unlocked	FW
05-06	Hunter Capital AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-28	Hunter Capital postpones interim report to May 7	FW

07-06	Hunter Capital RTO 1 : Hunter Capital RTO 1 AB (publ) provides an update on the planned transaction with ResoTher Pharma A/S	PU
03-30	Hunter Capital RTO 1 : Hunter Capital RTO 1 signs Letter of Intent for reverse takeover of Nordic Phase 2 biotech company at an implied valuation of SEK 365–405 million	PU
25-09-05	Hunter Capital: Hunter Capital AB (publ) acquires warrants and shares in SynAct Pharma AB (publ) from Heights Capital Management	PU

Manager	Title	Age	Since
Jacob Alexander Eriksson CEO	Chief Executive Officer	34	2024-09-01

Director	Title	Age	Since
David Olhed BRD	Director/Board Member	42	2021-05-20
Oliver Alexander Aleksov CHM	Chairman	32	2022-12-31
Jacob Alexander Eriksson BRD	Director/Board Member	34	2022-12-31